Targeting an antioxidant to mitochondria decreases cardiac ischemia‐reperfusion injury

Mitochondrial oxidative damage contributes to a wide range of pathologies, including cardiovascular disorders and neurodegenerative diseases. Therefore, protecting mitochondria from oxidative damage should be an effective therapeutic strategy. However, conventional antioxidants have limited efficacy due to the difficulty of delivering them to mitochondria in situ. To overcome this problem, we developed mitochondria‐targeted antioxidants, typified by MitoQ, which comprises a lipophilic triphenylphosphonium (TPP) cation covalently attached to a ubiquinol antioxidant. Driven by the large mitochondrial membrane potential, the TPP cation concentrates MitoQ several hundred‐fold within mitochondria, selectively preventing mitochondrial oxidative damage. To test whether MitoQ was active in vivo, we chose a clinically relevant form of mitochondrial oxidative damage: cardiac ischemia‐reperfusion injury. Feeding MitoQ to rats significantly decreased heart dysfunction, cell death, and mitochondrial damage after ischemia‐reperfusion. This protection was due to the antioxidant activity of MitoQ within mitochondria, as an untargeted antioxidant was ineffective and accumulation of the TPP cation alone gave no protection. Therefore, targeting antioxidants to mitochondria in vivo is a promising new therapeutic strategy in the wide range of human diseases such as Parkinson's disease, diabetes, and Friedreich's ataxia where mitochondrial oxidative damage underlies the pathology. Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., Sammut, I. A. Targeting an antioxidant to mitochondria decreases cardiac ischemia‐reperfusion injury. FASEB J. 19, 1088–1095 (2005)

[1]  A. V. Cideciyan,et al.  Lifespan and mitochondrial control of neurodegeneration , 2004, Nature Genetics.

[2]  J. Joseph,et al.  Supplementation of Endothelial Cells with Mitochondria-targeted Antioxidants Inhibit Peroxide-induced Mitochondrial Iron Uptake, Oxidative Damage, and Apoptosis* , 2004, Journal of Biological Chemistry.

[3]  Robin A. J. Smith,et al.  Fine‐tuning the hydrophobicity of a mitochondria‐targeted antioxidant , 2004, FEBS letters.

[4]  D. Jackson,et al.  Neuroprotective effects of spermine following hypoxia‐ischemia‐induced brain damage: A mechanistic study , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  G. Paradies,et al.  Decrease in Mitochondrial Complex I Activity in Ischemic/Reperfused Rat Heart: Involvement of Reactive Oxygen Species and Cardiolipin , 2004, Circulation research.

[6]  L. Szweda,et al.  Cardiac ischemia/reperfusion, aging, and redox-dependent alterations in mitochondrial function. , 2003, Archives of biochemistry and biophysics.

[7]  M. Yacoub,et al.  Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. , 2003, Archives of biochemistry and biophysics.

[8]  G. Salama,et al.  Mitochondrial membrane potentials in ischemic hearts. , 2003, Archives of biochemistry and biophysics.

[9]  C. Hoppel,et al.  Ischemia-reperfusion injury in the aged heart: role of mitochondria. , 2003, Archives of biochemistry and biophysics.

[10]  Robin A. J. Smith,et al.  Mitochondria‐targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Peipei Ping,et al.  Role of the mitochondrial permeability transition in myocardial disease. , 2003, Circulation research.

[12]  Robin A. J. Smith,et al.  Delivery of bioactive molecules to mitochondria in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Borutaite,et al.  Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. , 2003, Journal of molecular and cellular cardiology.

[14]  Y. Kaneda,et al.  Heat Shock Protein 72 Enhances Manganese Superoxide Dismutase Activity During Myocardial Ischemia-Reperfusion Injury, Associated With Mitochondrial Protection and Apoptosis Reduction , 2002, Circulation.

[15]  Robin A. J. Smith,et al.  Prevention of Mitochondrial Oxidative Damage Using Targeted Antioxidants , 2002, Annals of the New York Academy of Sciences.

[16]  C. Patterson,et al.  Postischemic Recovery of Contractile Function is Impaired in SOD2+/− but Not SOD1+/− Mouse Hearts , 2002, Circulation.

[17]  J. Hoerter,et al.  Water content and its intracellular distribution in intact and saline perfused rat hearts revisited. , 2002, Cardiovascular research.

[18]  G. Brown,et al.  Release of mitochondrial cytochrome c and activation of cytosolic caspases induced by myocardial ischaemia. , 2001, Biochimica et biophysica acta.

[19]  M. Yacoub,et al.  Heat stress contributes to the enhancement of cardiac mitochondrial complex activity. , 2001, The American journal of pathology.

[20]  M. Murphy,et al.  How understanding the control of energy metabolism can help investigation of mitochondrial dysfunction, regulation and pharmacology. , 2001, Biochimica et biophysica acta.

[21]  Robin A. J. Smith,et al.  Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells , 2001, The Journal of Biological Chemistry.

[22]  B. Robinson,et al.  Mitochondria, oxygen free radicals, disease and ageing. , 2000, Trends in biochemical sciences.

[23]  B. Kalyanaraman,et al.  Mitochondrial Aconitase Is a Source of Hydroxyl Radical , 2000, The Journal of Biological Chemistry.

[24]  Robin A. J. Smith,et al.  Drug delivery to mitochondria: the key to mitochondrial medicine. , 2000, Advanced drug delivery reviews.

[25]  D. Wallace.  Mitochondrial diseases in man and mouse. , 1999, Science.

[26]  Y. Ho,et al.  Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. , 1998, Journal of molecular and cellular cardiology.

[27]  M. Murphy,et al.  Selective targeting of bioactive compounds to mitochondria. , 1997, Trends in biotechnology.

[28]  M. Murphy,et al.  Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. , 1996, The Biochemical journal.

[29]  V. Darley-Usmar,et al.  Reoxygenation-dependent decrease in mitochondrial NADH:CoQ reductase (Complex I) activity in the hypoxic/reoxygenated rat heart. , 1991, The Biochemical journal.

[30]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Weisfeldt,et al.  Direct measurement of free radical generation following reperfusion of ischemic myocardium. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Kawada,et al.  Effects of 6-(omega-substituted alkyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinones and related compounds on mitochondrial succinate and reduced nicotinamide adenine dinucleotide oxidase systems. , 1985, Chemical & pharmaceutical bulletin.

[33]  O. Sugita,et al.  [Lactate dehydrogenase]. , 1984, Rinsho byori. The Japanese journal of clinical pathology.

[34]  H. Beinert,et al.  The role of iron in the activation-inactivation of aconitase. , 1983, The Journal of biological chemistry.

[35]  Steven J. Steindel,et al.  4 Lactate Dehydrogenase , 1975 .

[36]  E. Bernt,et al.  UV-Assay with Pyruvate and NADH , 1974 .

[37]  V. Skulachev,et al.  Conversion of biomembrane-produced energy into electric form. IV. General discussion. , 1970, Biochimica et biophysica acta.

[38]  E A Liberman,et al.  Conversion of biomembrane-produced energy into electric form. I. Submitochondrial particles. , 1970, Biochimica et biophysica acta.

[39]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.